Most liked #monkeypox videos on TikTok: Implications for infection control - 20/12/23
Doi : 10.1016/j.ajic.2023.06.021
Corey H. Basch, EdD, MPH a, ⁎ 
, Bhavya Yalamanchili, BS a, Joseph Fera, PhD b, Sandhya Narayanan, EdD, MS a
, Bhavya Yalamanchili, BS a, Joseph Fera, PhD b, Sandhya Narayanan, EdD, MS a a Department of Public Health, William Paterson University, Wayne, NJ
b Department of Mathematics, Lehman College, The City University of New York, Bronx, NY
⁎Address correspondence to Corey H. Basch, EdD, MPH, Department of Public Health, William Paterson University, University Hall, Wayne, NJ 07470.Department of Public Health, William Paterson University, University HallWayneNJ07470
Resumen |
This cross-sectional study describes the content of the 100 most liked videos on TikTok using the hashtag #monkeypox. The videos in the sample received 472,866,669 views and 56,434,700 likes. Most (67%) of the videos were created by consumers. Mentions or suggestions of exposure were the only content characteristic included in a majority of the videos (N = 54). Over a third of the sample used parody, memes, or satire (38%), which were derogatory.
El texto completo de este artículo está disponible en PDF.Highlights |
• | Monkeypox is being widely discussed on TikTok. |
• | Over one-third of the videos used mocked those who were infected with the virus. |
• | Prevention was discussed in only a small percent of the videos. |
Key Words : Social media, Prevention
Esquema
| Conflicts of interest: None to report. |
© 2023
Association for Professionals in Infection Control and Epidemiology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 52 - N° 1
P. 123-124 - janvier 2024 Regresar al número
Artículo precedente
- A narrative review of how infection preventionist (IP) staffing and outcome metrics are assessed by health care organizations and factors to consider
- Shanina C Knighton, Joshua Engle, Julia Berkson, Rebecca Bartles
- Impact of prior COVID-19 infection on perceptions about the benefit and safety of COVID-19 vaccines
- Alistair Thorpe, Andrea Gurmankin Levy, Laura D. Scherer, Aaron M. Scherer, Frank A. Drews, Jorie M. Butler, Angela Fagerlin
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?